Navigation Links
Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues
Date:5/12/2008

NEW YORK, May 12 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) commends the Senate on its passage of a resolution supporting the goals and ideals of National Women's Health Week that begins annually on Mother's Day. The resolution, introduced by Senators Russ Feingold (D-WI) and Olympia Snowe (R-ME) calls on all Americans to take the week of May 11th - May 17th as an opportunity to educate themselves on women's health issues, and recognizes the importance of Federally funded programs that provide research on common diseases in women, like lupus. ALR's main legislative priority is increased support for lupus research by Federal agencies such as the National Institute for Health, Health and Human Services, and Department of Defense Health Programs. The House version of the resolution introduced by Rep. Maurice Hinchey (NY-D) is expected to pass this week.

"Too many women - our nation's mothers, daughters, sisters, and grandmothers - are affected by lupus, a devastating autoimmune disease. We are pleased that Congress is honoring National Women's Health Week along with the ALR, by officially recognizing the importance of education and continued Federal research funding for lupus and other women's health issues," says ALR President Barbara Boyts.

Lupus causes unpredictable symptoms ranging from fatigue and joint pain to severe organ damage, and complications from the disease often prove fatal. The resolution properly recognizes that significant disparities exist in the prevalence of disease among women of different backgrounds. Not only are women in their childbearing years nine times more likely than men to develop lupus, but women of African-American descent are three times more likely to be diagnosed with the disease. Women of Asian, Latin American/Hispanic, Pacific Rim descent are also more likely to be affected. An estimated 1.4 million Americans have lupus.

"This disease disproportionately strikes a typically me
'/>"/>

SOURCE Alliance for Lupus Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
2. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
3. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
6. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
7. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
8. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
9. Aida Announces New Anti-Cancer Drug Under Development
10. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
11. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec...s today announced the signing of an agreement to p...sing SoftGenetics, NextGENe software for next-gene..., (Logo: http://www.newscom.com/cgi-bin/prnh/... Ambry,s CSO said, "Our team at Ambry has been pro...
(Date:12/3/2009)... , DOYLESTOWN, Pa., Dec. 3 /PRNewswire-FirstCa... Corporation, (Nasdaq: QGLY ) www.quigleyco.com ...s evaluation of its opportunities to develop presc...ncluded that it is in its best interests to focus ...ich may include but are not limited to its Cold-EE...
(Date:12/3/2009)..., WILMINGTON, Del., Dec. 3 Parag...rmaceutical risk management and optimal medication...9, on the FDA,s draft guidance on REMS - Risk Eval...ications for REMS lifecycle management. Dr. Gary ...expert on REMS and risk management programs, will ...
Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 1Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 2Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 1Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 2Prime Therapeutics 2009 Drug Trend Insights Shows Drug Spending Slows to Lowest Rate on Record 54189 3Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets 54186 1Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets 54186 2
...te phase III trial - , , SOUTH SAN FRANCISCO, Cal...nnounced top-line results from their phase II stud...ders. The data was presented on March 27th at the...ican College of Medical Genetics by Brendan Lee, M...igator and Professor Department of Molecular and H...
... in combination with the most commonly used doses ...tients with mixed dyslipidemia , , ORLANDO, Fla.,...tt ,s TRILIPIX(R) (fenofibric acid) delayed-releas...m met all of the study,s primary endpoints. TRILI...m 5 mg significantly improved HDL cholesterol and ...
Other Medicine Technology:Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 2Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 3Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 4New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 2New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 3New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 4New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 5
(Date:12/3/2009)...rn causes demand for affordable drug and alcohol r... sharp increase in demand for its services and att... led to an increase in alcoholic binge drinking, d... (PRWEB) December 3, 2009 -- Mountainside ...spike in demand for its services due to the econom...
(Date:12/3/2009)... of screening test, researcher says, , ...rch points to the possibility of a genetic link be...h high blood pressure who had a gene variant that ...d to be twice as likely as those without the varia...nd. , The finding may lead to a way to identify...
(Date:12/3/2009)...ewswire-USNewswire/ -- The American Association fo...rom one of the largest studies to date on passive ...e Northern California Cancer Center (NCCC) . ,...d cigarettes and who were exposed to secondhand ci...dulthood--had a significantly increased breast can...
(Date:12/3/2009)...PRNewswire-USNewswire/ -- The Board of Trustees of...mously voted to elect three new members during its... is co-founder and Managing Director of De Novo Ve...650 million from three funds in early stage medica...ded Medicus Venture Partners in 1989. He has inves...
(Date:12/3/2009)... For California,s 3.4 million owne...remains one of the most significant threats to not...o their business,s viability. ,, "As the reces...ners of small businesses are recognizing the need ...ed disability coverage," said Michael Hagedorn, ...
Breaking Medicine News(10 mins):Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4
...ealth Status; Anthem Blue Cross and Blue, Shield p...more than 5,000, Kentuckians located in the easte...LLE, Ky., Nov. 14 Anthem Blue Cross and Blue,Shie...tate. Anthem has assembled a dedicated team to col...
...s first diagnosed in childhood , , WEDNESD...be 87 years old, but he still remembers the day ...1925. , "I went to the hospital at five years of a...aid Cleveland, of Syracuse, N.Y. , He didn,t die....
...f frustration from,those who live with the risk of...tudies suggest that the comprehensive and often co...ming diabetes patients to the point,of inaction. S...ss of incorporating a complete diabetes management...
...uarter Ended September 30, 2007 ...348 Average Patient Charge (APC) ... uncompensated care as a percent of gross revenue .../Metro,Corporation (Nasdaq: RURL ), a leading pro...
...rug development platform, SEATTLE, Nov. 14 Analy... the progress and prospects of three of Cell,Thera...IC) oncology drug,candidates, as well as informati...Strategies, New Opportunities",in New York on Frid...
...tal, the nation,s,largest and most experienced den...Award from Benefits Selling magazine as the dental... design and network availability. The,awards were ...rences in eight categories that are determined to,...
Other Medicine News:Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 2Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 3Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 4Health News:A Full and Long Life, Despite Diabetes 2Health News:A Full and Long Life, Despite Diabetes 3Health News:A Full and Long Life, Despite Diabetes 4Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 2Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 3Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 2Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 3Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 4Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 5Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 6Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 7Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 8Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 9Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 10Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 11Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 12Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 13Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 14Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 15Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 16Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 17Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 18Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 19Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 20Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 21Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 22Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 23Health News:Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year 24Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 2Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 3Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 4Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 5
...eye protection Properly manufactured radiation pr...f scatter radiation. Our high quality frames and m...h minimized weight. Our lenses are made of Schott ... standards. Most Pulse Glasses are offered with le...
...re designed with the safety and comfort of the pra...lso called SF-6) leaded glass, the industry standa...t standards, as set for optical clarity, visible l...While our eyewear is protecting your eyes, it also...
...re designed with the safety and comfort of the pra...lso called SF-6) leaded glass, the industry standa...t standards, as set for optical clarity, visible l...While our eyewear is protecting your eyes, it also...
Glasses,metal,trifocal
Medicine Products: